ELVIRA GUTIERREZ: Open Payments
NPI 1174613178 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 11 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $152 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $126 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Bioventus LLC | 1 | $29 |
| Novo Nordisk Inc | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: BOTOX, SHINGRIX, FARXIGA, GELSYN-3, Ozempic, MOUNJARO, ZEPBOUND, BREZTRI.
Industry payments across NJ — which companies pay providers there.
